JG
NVAX icon

Joel Greenblatt’s Novavax NVAX Stock Holding History

Joel Greenblatt’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-86,608
Closed -$9.66M – 1055
2020
Q4 		$9.66M Sell
86,608
-52
-0.1% -$5.53K 0.32% 80
2020
Q3 		$9.39M Sell
86,660
-31,981
-27% -$3.9M 0.3% 90
2020
Q2 		$9.89M Buy
+118,641
New +$4.54M 0.3% 84
2015
Q4 		– Sell
-5,532
Closed -$782K – 961
2015
Q3 		$782K Buy
+5,532
New +$1.24M 0.01% 652

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Joel Greenblatt's NVAX Position: Q1 2021 in Review

Joel Greenblatt sold out of Novavax (NVAX) in Q1 2021, closing a stake of 86,608 shares — an estimated $9.66M sold.

Joel Greenblatt first reported a position in NVAX in Q3 2015 and held it in 4 quarters. The position peaked at $9.89M in Q2 2020. 390 funds tracked by Wall St. Rank hold NVAX as of Q1 2021.

  • Joel Greenblatt reported no remaining Novavax position as of Q1 2021 after selling out during the quarter.
  • Joel Greenblatt sold 86,608 Novavax shares in Q1 2021, an estimated $9.66M.
  • Joel Greenblatt first reported a position in Novavax in Q3 2015 and held it in 4 quarters.
  • Joel Greenblatt's Novavax position peaked at $9.89M in Q2 2020.
  • 390 funds tracked by Wall St. Rank held Novavax as of Q1 2021.

Based on Gotham Asset Management's 13F filing for Q1 2021, filed 17 May 2021.